•
Sep 30, 2022

Vaxart Q3 2022 Earnings Report

EPS
-$0.23
Previous year: -$0.14
+64.3%
Cash and Equivalents
$50.8M
Previous year: $167M
-69.6%
Free Cash Flow
-$16.6M
Previous year: -$15.6M
+6.7%
Total Assets
$175M
Previous year: $241M
-27.3%

Vaxart

Vaxart